Skip to main content
Fig. 4 | Clinical Proteomics

Fig. 4

From: Quantitative proteomics identifies and validates urinary biomarkers of rhabdomyosarcoma in children

Fig. 4

Pattern recognition analysis (OPLS-DA) of 251 differential proteins among RN0, RN1, RS0, RS1, and HC identified by DIA strategy. OPLS-DA orthogonal projection to latent structures discriminant analysis, RN0 newly diagnosed RMS at the time points of admission, RN1 newly diagnosed RMS at the time points after 4 cycles of chemotherapy, RS0 RMS underwent surgery at the time points of admission, RS1 RMS underwent surgery at the time points after 4 cycles of chemotherapy, HC healthy control

Back to article page